DESIGN THERAPEUTICS INC (DSGN) Stock Analyst Earnings Estimates
NASDAQ:DSGN - Nasdaq - US25056L1035 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 830K | 230K -72.29% | -100.00% | 5.1M | 55.083M 980.06% | 196.59M 256.90% | 394.81M 100.83% | 692.32M 75.36% | |||||||
| EBITDA YoY % growth | N/A | -8.32M | -39.135M -329.09% | -69.3M -88.18% | -79.501M -15.59% | -92.31M -18.87% | -107.424M -16.37% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.91M | -8.33M -336.13% | -38.106M -330.13% | -69.193M -88.64% | -84.211M -15.68% | -63.769M 18.44% | -77.02M -20.78% | -85.742M -11.32% | -117.138M -36.62% | -167.423M -42.93% | -201.055M -20.09% | -133.803M 33.45% | 10.341M 107.73% | 262.46M 2,438.05% | |
| Operating Margin | -230.12% | -3,621.74% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -3,282.80% | -365.00% | -68.06% | 2.62% | 37.91% | |
| EPS YoY % growth | N/A | N/A | -0.82 | -1.19 -32.56% | -1.32 -5.26% | -0.92 23.50% | -1.24 -34.81% | -1.17 5.77% | -1.21 -3.64% | -1.57 -29.54% | -1.27 18.89% | -0.59 53.41% | 0.36 161.21% | 1.76 387.32% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.27 -29.53% | -0.29 -45.35% | -0.29 -38.43% | -0.30 -30.83% | -0.31 -14.37% | -0.36 -22.81% | -0.36 -22.81% | -0.37 -22.03% | -0.38 -21.31% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -17.163M -13.50% | -17.458M -21.23% | -17.884M -18.88% | -18.451M -13.57% | -19.242M -12.12% | -21.332M -22.19% | -21.84M -22.12% | -22.362M -21.20% | -23.211M -20.63% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.23 17.86% | -0.25 | 0.02 | 7.33% |
| Q2 2024 Q2Q % growth | -0.21 41.67% | -0.24 | 0.03 | 11.76% |
| Q1 2024 Q2Q % growth | -0.20 42.86% | -0.27 | 0.07 | 25.54% |
| Q4 2023 Q2Q % growth | -0.21 32.26% | -0.32 | 0.11 | 33.53% |
| Q3 2023 Q2Q % growth | -0.28 12.50% | -0.42 | 0.14 | 32.80% |
| Q2 2023 Q2Q % growth | -0.36 -33.33% | -0.41 | 0.05 | 11.21% |
| Q1 2023 Q2Q % growth | -0.35 -45.83% | -0.37 | 0.02 | 4.49% |
| Q4 2022 Q2Q % growth | -0.31 -55.00% | -0.35 | 0.04 | 11.65% |
| Q3 2022 Q2Q % growth | -0.32 -52.38% | -0.29 | -0.03 | -8.93% |
| Q2 2022 Q2Q % growth | -0.27 -92.86% | -0.26 | -0.02 | -5.88% |
| Q1 2022 Q2Q % growth | -0.24 22.58% | -0.22 | -0.02 | -6.95% |
| Q4 2021 Q2Q % growth | -0.20 | -0.23 | 0.03 | 13.50% |
| Q3 2021 Q2Q % growth | -0.21 | -0.14 | -0.07 | -47.06% |
| Q2 2021 Q2Q % growth | -0.14 | -0.19 | 0.05 | 25.13% |
| Q1 2021 Q2Q % growth | -0.31 | -0.07 | -0.24 | -314.46% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 2.44% | 0% | 1.46% |
| Revenue | N/A | N/A | N/A | N/A |